These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14531924)

  • 1. Malignancies in sickle cell disease patients treated with hydroxyurea.
    Ferster A; Sariban E; Meuleman N;
    Br J Haematol; 2003 Oct; 123(2):368-9. PubMed ID: 14531924
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea.
    Wilson S
    Ann Intern Med; 2000 Dec; 133(11):925-6. PubMed ID: 11103075
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term use of hydroxyurea for sickle cell anemia.
    Spell DW
    JAMA; 2003 Aug; 290(6):752; author reply 754. PubMed ID: 12915422
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxyurea for sickle cell anemia.
    Bachmeyer C; Aractingi S; Lionnet F
    N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18609755
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia.
    Taylor JG; Darbari DS; Maric I; McIver Z; Arthur DC
    Ann Intern Med; 2011 Nov; 155(10):722-4. PubMed ID: 22084346
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxyurea in very young children with sickle cell anemia is not a cure-all.
    Powars DR
    J Pediatr; 2001 Dec; 139(6):763-4. PubMed ID: 11743496
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxyurea-induced splenic regrowth in an adult patient with severe hemoglobin SC disease.
    Huang Y; Ananthakrishnan T; Eid JE
    Am J Hematol; 2003 Oct; 74(2):125-6. PubMed ID: 14508799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea for the treatment of sickle cell anemia.
    Platt OS
    N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
    [No Abstract]   [Full Text] [Related]  

  • 9. Are we underestimating the leukemogenic risk of hydroxyurea.
    Al-Jam'a AH; Al-Dabbous IA; Al-Khatti AA; Esan FG
    Saudi Med J; 2002 Nov; 23(11):1411-3. PubMed ID: 12506308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy.
    O'branski EE; Ware RE; Prose NS; Kinney TR
    J Am Acad Dermatol; 2001 May; 44(5):859-61. PubMed ID: 11312437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.
    Obaro SK
    Lancet Glob Health; 2015 Mar; 3(3):e124-5. PubMed ID: 25701988
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.
    Olujohungbe A; Cinkotai KI; Yardumian A
    BMJ; 1998 Jun; 316(7146):1689. PubMed ID: 9614013
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease.
    Gille AS; Pondarré C; Dalle JH; Bernaudin F; Chalas C; Fahd M; Jean C; Lezeau H; Riou L; Drouineaud V; Paye-Jaouen A; Kamdem A; Neven B; Arnaud C; Azarnoush S; Yakouben K; Sarnacki S; de Montalembert M; Comperat EM; Lenaour G; Sibony M; Dhédin N; Vaiman D; Wolf JP; Patrat C; Fouchet P; Poirot C; Barraud-Lange V
    Blood; 2021 Feb; 137(6):856-859. PubMed ID: 33259585
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment.
    Berthaut I; Bachir D; Kotti S; Chalas C; Stankovic K; Eustache F; Ravel C; Habibi A; Brailly-Tabard S; Lévy-Dutel L; Bleibtreu A; Simon T; Galactéros F; Lionnet F; Mandelbaum J
    Blood; 2017 Nov; 130(21):2354-2356. PubMed ID: 28972009
    [No Abstract]   [Full Text] [Related]  

  • 15. [Edifying affair of hydroxycarbamid].
    Nau JY
    Rev Med Suisse; 2008 Apr; 4(152):940. PubMed ID: 18578439
    [No Abstract]   [Full Text] [Related]  

  • 16. Sickle cell pain crisis.
    Davies SC; Bevan DH
    Lancet; 1996 Jan; 347(8996):263. PubMed ID: 8551907
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxycarbamide for sickle-cell anaemia in infancy.
    Weatherall DJ
    Lancet; 2011 May; 377(9778):1628-30. PubMed ID: 21571132
    [No Abstract]   [Full Text] [Related]  

  • 18. Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report.
    Bhangu G; Uminski K; Roessner C; Goodyear D; Sale T; Rydz N
    Ann Hematol; 2024 Aug; 103(8):3277-3279. PubMed ID: 38630130
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. French Study Group on Sickle Cell Disease.
    de Montalembert M; Bégué P; Bernaudin F; Thuret I; Bachir D; Micheau M
    Arch Dis Child; 1999 Nov; 81(5):437-9. PubMed ID: 10519721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment.
    Fattori A; de Souza RA; Saad ST; Costa FF
    Hematol J; 2005; 5(7):589-90. PubMed ID: 15692605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.